Puerto Rico
- Overview
- Obesity prevalence
- Population breakdowns
- Drivers
- Comorbidities
- Policies
Loading data – please wait …
National obesity risk *8/10This is a composite ‘obesity risk’ score (out of 10, the highest risk) based on obesity prevalence, rate of increase, likelihood of meeting the 2025 target, treatment indicator and childhood stunting levels.Childhood obesity risk *4/11This is a ‘risk score’ for each country’s likelihood of having or acquiring a major childhood obesity problem during the 2020s, taking account of current prevalence levels and risk for future obesity (based on stunting among infants, maternal obesity, maternal smoking, and breastfeeding rates).
Obesity prevalence
Download report card
The report card collates all the most-recent graphics for this country. If you would like to produce a custom report based on selected graphics, just tap the Add to custom PDF button below the graphics you would like to use.Population breakdowns
Drivers
Comorbidities
Obesity prevalence
Children, 2010-2011
| Survey type: | Measured |
| Age: | 12 |
| Sample size: | 1582 |
| References: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4358900/ (last accessed 09.03.22) |
| Notes: | A probabilistic sample of 133 schools was selected from a total of 1,843 schools. Ten boys and ten girls were randomly selected from each school using the official student lists provided by the school’s administration. The required sample size was 2,600 children. A total of 1,734 children were contacted and invited to participate, however, some of the selected schools were inactive and others had merged. 152 children were excluded due to school absences and failure to obtain their parent’s written consent. |
| Definitions: | Children were categorized as overweight, or obese using the Center for Disease Control and Prevention's age and gender specific growth charts. |
| Cutoffs: | CDC |
Overweight/obesity by education
Adults, 2005-2007
| Survey type: | Measured |
| Age: | 45-52 |
| Sample size: | 840 |
| Area covered: | Regional - San Juan Metropolitan Area |
| References: | Prevalence of overweight and obesity and their cardiometabolic comorbidities in Hispanic adults living in San Juan Metropolitan Area, Puerto Rico https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3823746/ (last accessed 09.03.22) |
| Unless otherwise noted, overweight refers to a BMI between 25kg and 29.9kg/m², obesity refers to a BMI greater than 30kg/m². | |
Overweight/obesity by age
Adults, 2005-2007
| Survey type: | Measured |
| Sample size: | 840 |
| Area covered: | Regional - San Juan Metropolitan Area |
| References: | Prevalence of overweight and obesity and their cardiometabolic comorbidities in Hispanic adults living in San Juan Metropolitan Area, Puerto Rico https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3823746/ (last accessed 09.03.22) |
| Unless otherwise noted, overweight refers to a BMI between 25kg and 29.9kg/m², obesity refers to a BMI greater than 30kg/m². | |
Estimated per capita fruit intake
Adults, 2017
| Survey type: | Measured |
| Age: | 25+ |
| References: | Global Burden of Disease, the Institute for Health Metrics and Evaluation http://ghdx.healthdata.org/ |
| Definitions: | Estimated per-capita fruit intake (g/day) |
Estimated per-capita processed meat intake
Adults, 2017
| Survey type: | Measured |
| Age: | 25+ |
| References: | Global Burden of Disease, the Institute for Health Metrics and Evaluation http://ghdx.healthdata.org/ |
| Definitions: | Estimated per-capita processed meat intake (g per day) |
Estimated per capita whole grains intake
Adults, 2017
| Survey type: | Measured |
| Age: | 25+ |
| References: | Global Burden of Disease, the Institute for Health Metrics and Evaluation http://ghdx.healthdata.org/ |
| Definitions: | Estimated per-capita whole grains intake (g/day) |
Oesophageal cancer
Men, 2018
| Age: | 20+ |
| References: | Global Cancer Observatory, Cancer incidence rates http://gco.iarc.fr/ (last accessed 30th June 2020) |
| Definitions: | Estimated age-standardized incidence rates (World) in 2018, oesophagus, adults ages 20+. ASR (World) per 100,000 |
Women, 2018
| Age: | 20+ |
| References: | Global Cancer Observatory, Cancer incidence rates http://gco.iarc.fr/ (last accessed 30th June 2020) |
| Definitions: | Estimated age-standardized incidence rates (World) in 2018, oesophagus, adults ages 20+. ASR (World) per 100,000 |
Breast cancer
Women, 2018
| Age: | 20+ |
| References: | Global Cancer Observatory, Cancer incidence rates http://gco.iarc.fr/ (last accessed 30th June 2020) |
| Definitions: | Estimated age-standardized incidence rates (World) in 2018, breast, females, ages 20+. ASR (World) per 100,000 |
Colorectal cancer
Men, 2018
| Age: | 20+ |
| References: | Global Cancer Observatory, Cancer incidence rates http://gco.iarc.fr/ (last accessed 30th June 2020) |
| Definitions: | Estimated age-standardized incidence rates (World) in 2018, colorectum, adults, ages 20+. ASR (World) per 100,000 |
Women, 2018
| Age: | 20+ |
| References: | Global Cancer Observatory, Cancer incidence rates http://gco.iarc.fr/ (last accessed 30th June 2020) |
| Definitions: | Estimated age-standardized incidence rates (World) in 2018, colorectum, adults, ages 20+. ASR (World) per 100,000 |
Pancreatic cancer
Men, 2018
| Age: | 20+ |
| References: | Global Cancer Observatory, Cancer incidence rates http://gco.iarc.fr/ (last accessed 30th June 2020) |
| Definitions: | Estimated age-standardized incidence rates (World) in 2018, pancreas, adults, ages 20+. ASR (World) per 100,000 |
Women, 2018
| Age: | 20+ |
| References: | Global Cancer Observatory, Cancer incidence rates http://gco.iarc.fr/ (last accessed 30th June 2020) |
| Definitions: | Estimated age-standardized incidence rates (World) in 2018, pancreas, adults, ages 20+. ASR (World) per 100,000 |
Gallbladder cancer
Men, 2018
| Age: | 20+ |
| References: | Global Cancer Observatory, Cancer incidence rates http://gco.iarc.fr/ (last accessed 30th June 2020) |
| Definitions: | Estimated age-standardized incidence rates (World) in 2018, gallbladder, adults, ages 20+. ASR (World) per 100,000 |
Women, 2018
| Age: | 20+ |
| References: | Global Cancer Observatory, Cancer incidence rates http://gco.iarc.fr/ (last accessed 30th June 2020) |
| Definitions: | Estimated age-standardized incidence rates (World) in 2018, gallbladder, adults, ages 20+. ASR (World) per 100,000 |
Kidney cancer
Men, 2018
| Age: | 20+ |
| References: | Global Cancer Observatory, Cancer incidence rates http://gco.iarc.fr/ (last accessed 30th June 2020) |
| Definitions: | Estimated age-standardized incidence rates (World) in 2018, kidney, adults, ages 20+. ASR (World) per 100,000 |
Women, 2018
| Age: | 20+ |
| References: | Global Cancer Observatory, Cancer incidence rates http://gco.iarc.fr/ (last accessed 30th June 2020) |
| Definitions: | Estimated age-standardized incidence rates (World) in 2018, kidney, adults, ages 20+. ASR (World) per 100,000 |
Cancer of the uterus
Women, 2018
| Age: | 20+ |
| References: | Global Cancer Observatory, Cancer incidence rates http://gco.iarc.fr/ (last accessed 30th June 2020) |
| Definitions: | Estimated age-standardized incidence rates (World) in 2018, cervix uteri, females, ages 20+. ASR (World) per 100,000 |
Diabetes prevalence
Adults, 2021
| Age: | 20-79 |
| Area covered: | National |
| References: | Reproduced with kind permission International Diabetes Federation. IDF Diabetes Atlas, 10th edn. Brussels, Belgium:International Diabetes Federation, 2021. http://www.diabetesatlas.org |
| Definitions: | Age-adjusted comparative prevalence of diabetes, % |
Adults, 2019
| Age: | 20-79 |
| References: | Reproduced with kind permission International Diabetes Federation. IDF Diabetes Atlas, 9th edn. Brussels,Belgium: 2019. Available at: https://www.diabetesatlas.org |
| Definitions: | Diabetes age-adjusted comparative prevalence (%). |
Adults, 2017
| References: | Reproduced with kind permission of IDF, International Diabetes Federation. IDF Diabetes Atlas, 8th edition. Brussels, Belgium: International Diabetes Federation, 2017. http://www.diabetesatlas.org |
| Definitions: | Diabetes age-adjusted comparative prevalence (%). |
